134 related articles for article (PubMed ID: 20479396)
21. Does initial haemoglobin level modify the efficacy of radiosensitizers? An analysis of the MRC misonidazole studies in head and neck cancer and cervix cancer.
Freedman LS; Honess DJ; Bleehen NM; Adams GE; Dische S; Henk JM
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Dec; 52(6):965-7. PubMed ID: 3500934
[No Abstract] [Full Text] [Related]
22. [Intensity-modulated radiotherapy in head and neck cancer: ethics and methodology].
Lapeyre M; Biau J; Miroir J; Servagi-Vernat S; Giraud P
Cancer Radiother; 2014 Oct; 18(5-6):365-8. PubMed ID: 25179256
[TBL] [Abstract][Full Text] [Related]
23. [Chemoradiotherapy for patients with advanced head and neck cancer].
Tsukuda M
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
Rischin D; Fisher R; Peters L; Corry J; Hicks R
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S61-3. PubMed ID: 17848298
[No Abstract] [Full Text] [Related]
25. Lonidamine and radiotherapy in head and neck cancers. A pilot study.
Magno L; Terraneo F; Ciottoli GB
Oncology; 1984; 41 Suppl 1():113-5. PubMed ID: 6717889
[TBL] [Abstract][Full Text] [Related]
26. Clinical science and patient care: lessons from cooperative randomized clinical trials.
Cox JD
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):273-4. PubMed ID: 9308927
[No Abstract] [Full Text] [Related]
27. Taxol plus radiation for head and neck cancer.
Rosenthal DI; Carbone DP
J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
[TBL] [Abstract][Full Text] [Related]
28. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
[No Abstract] [Full Text] [Related]
29. [Clinical results and experiences with combination of radiotherapy and radiosensitizing agents].
Ikeda H
Gan No Rinsho; 1990 Oct; 36(13):2244-7. PubMed ID: 1701197
[TBL] [Abstract][Full Text] [Related]
30. At last--progress in the assessment of the adverse effects of cancer treatments.
Horiot JC
Lancet Oncol; 2007 Jul; 8(7):568-70. PubMed ID: 17613419
[No Abstract] [Full Text] [Related]
31. Combined chemotherapy and radiation for unresectable head and neck cancer.
Taylor SG
Cancer Treat Res; 1990; 52():195-208. PubMed ID: 1976366
[No Abstract] [Full Text] [Related]
32. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
[TBL] [Abstract][Full Text] [Related]
33. Use of chemotherapy in the management of advanced head and neck cancers.
Giri PG
Kans Med; 1991 Dec; 92(12):311-3, 316. PubMed ID: 1800820
[No Abstract] [Full Text] [Related]
34. [Preclinical and clinical results in the simultaneous radiochemotherapy of head and neck tumors with Paclitaxel].
Hoffmann W; Heinrich V; Belka C; Budach W; Schmidberger H; Bochtler H; Rodemann HP; Bamberg M
Strahlenther Onkol; 1996 May; 172 Suppl 1():15-20. PubMed ID: 8633268
[No Abstract] [Full Text] [Related]
35. [Criteria for the determination of the efficacy of chemotherapy in head and neck cancer].
Inuyama Y
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2681-9. PubMed ID: 3740865
[No Abstract] [Full Text] [Related]
36. Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic index?
Harrington KJ; Nutting CM
Curr Opin Investig Drugs; 2002 May; 3(5):807-11. PubMed ID: 12090557
[No Abstract] [Full Text] [Related]
37. [New therapeutic strategy for head-and-neck neoplasms--Molecular target therapy].
Fujii M
Nihon Jibiinkoka Gakkai Kaiho; 2015 Nov; 118(11):1369-74. PubMed ID: 26897759
[No Abstract] [Full Text] [Related]
38. Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Overgaard J; Grau C
Acta Oncol; 2015; 54(9):1673-7. PubMed ID: 26397148
[No Abstract] [Full Text] [Related]
39. Combined-modality therapy of head and neck cancer.
Vokes EE
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 9):27-30. PubMed ID: 9330405
[TBL] [Abstract][Full Text] [Related]
40. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer.
Rosenthal DI; Lewin JS; Eisbruch A
J Clin Oncol; 2006 Jun; 24(17):2636-43. PubMed ID: 16763277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
